Advocacy for Impact Grants
A Global Competitive Grants Program for Patient Advocacy Groups
The application submission deadline has been extended. Applications may now be submitted through January 31, 2020.
Alnylam’s Advocacy for Impact Grants is a global competitive grants program that aims to inspire patient advocacy groups to develop solutions to address critical unmet needs in the rare disease communities they serve.
People with rare diseases often face unique challenges due to the complexity of their conditions, and we recognize that unique challenges call for creative solutions. We developed Advocacy for Impact Grants with that in mind, and because, at our core, we value and understand how exploring and developing new ideas has the potential to create high-impact initiatives that are a catalyst for change. In its second year, Advocacy for Impact Grants will continue to provide advocacy groups the resources and space to bring new projects and ideas to fruition.
In the inaugural year of Advocacy for Impact Grants, seven patient advocacy groups in six countries across three continents received grants totaling nearly US$250,000 to fund new initiatives supporting two rare diseases (Learn more about the 2018 recipients and their projects). This year, we are continuing our commitment to supporting patient advocacy groups in their efforts to develop solutions for the rare disease communities they serve.
Advocacy for Impact Grants is a global program, and Alnylam recognizes that unmet needs will differ across diverse communities and geographies. We encourage patient advocacy groups from around the world to apply with projects targeted to specifically meet the unique or special needs of their own communities. Groups can submit applications describing their new projects in any language.